Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis

Lignende værker

• Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
  af: Sharpley, Faye A., et al.
  Udgivet: (2020)
• DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
  af: Hutt, David, et al.
  Udgivet: (2015)
• A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
  af: Sharpley, Faye A., et al.
  Udgivet: (2019)
• Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis
  af: Manwani, Richa, et al.
  Udgivet: (2018)
• Updates in Cardiac Amyloidosis: A Review
  af: Banypersad, Sanjay M., et al.
  Udgivet: (2012)